Of note, we did not identify any heterogeneity among CTA-expressing tumours in that all cases which were found to be positive for CT10 and/or PRAME expressed the antigen relatively equally throughout all evaluated TMA cores (both high and low expressing tumours). This evidence concerns the gene MAGEC2 and neoplasm.